Potential Coronavirus Cure Dangerous to Mix with Others

The U.S. Food and Drug Administration warns of a potential drug interaction with remdesivir, which is considered a potential treatment for coronaviurs.

A few hours after canceling the emergency use of hydroxychloroquine and chloroquine for the treatment of COVID-19, the agency issued a warning that these drugs might interact with remdezivir from Gilead Sciences, potentially reducing its antiviral activity.

Remdesivir, also authorized under the EUA, is currently the only drug approved for use in severe cases of COVID-19.

“The combined use of remdesivir and chloroquine phosphate or hydroxychloroquine sulfate is not recommended, as this can lead to a loss in the effectiveness of the drug, the first preclinical tests showed,” the management said.